Cargando…
Initiation of prolyl cis-trans isomerisation in the CDR-H3 loop of an antibody in response to antigen binding
Proline cis-trans isomerisation is a regulatory mechanism used in a range of biological processes, and is related to various diseases such as Alzheimers disease and cancer. However, the details of the exact molecular mechanism by which it occurs are not known. Using X-ray crystallography, proline is...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5717248/ https://www.ncbi.nlm.nih.gov/pubmed/29208911 http://dx.doi.org/10.1038/s41598-017-16766-8 |
_version_ | 1783284103805665280 |
---|---|
author | Shinoda, Keiko Fujitani, Hideaki |
author_facet | Shinoda, Keiko Fujitani, Hideaki |
author_sort | Shinoda, Keiko |
collection | PubMed |
description | Proline cis-trans isomerisation is a regulatory mechanism used in a range of biological processes, and is related to various diseases such as Alzheimers disease and cancer. However, the details of the exact molecular mechanism by which it occurs are not known. Using X-ray crystallography, proline isomerisation has been shown to occur following formation of an antigen-antibody complex between the target epiregulin (EPR) and the antibody 9E5, at proline (Pro103), located in the third complementarity-determining region (CDR) of the heavy chain of 9E5. To obtain an accurate description of the pathway involved in cis-trans isomerisation in this system, we performed ten independent long molecular dynamics (MD) simulations starting at a stable transient bound structure obtained from many short binding MD simulations. As a result, we were able to describe the process by which cis-trans isomerisation is initiated, and suggest a catalysis mechanism for cis-trans isomerization in this antigen-antibody system. We found that Asp102, which is immediately adjacent to Pro103, rotates while changing its interacting partner residues in the light chain of 9E5, and at the same time EPR polar residues help to stabilise the intermediate states in the isomerisation process by interacting strongly with Asp102. |
format | Online Article Text |
id | pubmed-5717248 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-57172482017-12-08 Initiation of prolyl cis-trans isomerisation in the CDR-H3 loop of an antibody in response to antigen binding Shinoda, Keiko Fujitani, Hideaki Sci Rep Article Proline cis-trans isomerisation is a regulatory mechanism used in a range of biological processes, and is related to various diseases such as Alzheimers disease and cancer. However, the details of the exact molecular mechanism by which it occurs are not known. Using X-ray crystallography, proline isomerisation has been shown to occur following formation of an antigen-antibody complex between the target epiregulin (EPR) and the antibody 9E5, at proline (Pro103), located in the third complementarity-determining region (CDR) of the heavy chain of 9E5. To obtain an accurate description of the pathway involved in cis-trans isomerisation in this system, we performed ten independent long molecular dynamics (MD) simulations starting at a stable transient bound structure obtained from many short binding MD simulations. As a result, we were able to describe the process by which cis-trans isomerisation is initiated, and suggest a catalysis mechanism for cis-trans isomerization in this antigen-antibody system. We found that Asp102, which is immediately adjacent to Pro103, rotates while changing its interacting partner residues in the light chain of 9E5, and at the same time EPR polar residues help to stabilise the intermediate states in the isomerisation process by interacting strongly with Asp102. Nature Publishing Group UK 2017-12-05 /pmc/articles/PMC5717248/ /pubmed/29208911 http://dx.doi.org/10.1038/s41598-017-16766-8 Text en © The Author(s) 2017 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/. |
spellingShingle | Article Shinoda, Keiko Fujitani, Hideaki Initiation of prolyl cis-trans isomerisation in the CDR-H3 loop of an antibody in response to antigen binding |
title | Initiation of prolyl cis-trans isomerisation in the CDR-H3 loop of an antibody in response to antigen binding |
title_full | Initiation of prolyl cis-trans isomerisation in the CDR-H3 loop of an antibody in response to antigen binding |
title_fullStr | Initiation of prolyl cis-trans isomerisation in the CDR-H3 loop of an antibody in response to antigen binding |
title_full_unstemmed | Initiation of prolyl cis-trans isomerisation in the CDR-H3 loop of an antibody in response to antigen binding |
title_short | Initiation of prolyl cis-trans isomerisation in the CDR-H3 loop of an antibody in response to antigen binding |
title_sort | initiation of prolyl cis-trans isomerisation in the cdr-h3 loop of an antibody in response to antigen binding |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5717248/ https://www.ncbi.nlm.nih.gov/pubmed/29208911 http://dx.doi.org/10.1038/s41598-017-16766-8 |
work_keys_str_mv | AT shinodakeiko initiationofprolylcistransisomerisationinthecdrh3loopofanantibodyinresponsetoantigenbinding AT fujitanihideaki initiationofprolylcistransisomerisationinthecdrh3loopofanantibodyinresponsetoantigenbinding |